Tag: Novo Nordisk

Should You Invest In “Miracle Drug” Ozempic?

Posted by Adam O'Dell | Nov 17, 2023 | Banyan Edge, Diversified Investments, Trending

From Chealsea Handler to Elon Musk, Novo Nordisk’s Ozempic has been hailed a “miracle drug.” Is it worth investing in?

Read More

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

John Wilkinson
Director of VIP Services
Andrew Prince
Research Analyst
Charles Mizrahi
Editor of Alpha Investor
Amber Lancaster
Director of Investment Research
Banyan Hill
Ian King
Editor of Strategic Fortunes and three elite services
Adam O'Dell
Investment Strategist
Aaron James
CEO of Banyan Hill
Michael Carr
Editor of One Trade and Precision Profits

WHAT READERS ARE SAYING..

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.